CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

Clinical trial NCT05620680 · RECRUITING

Trial details

NCT number: NCT05620680
Sponsor: Shenzhen University General Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

T Lymphoblastic Leukemia/Lymphoma

Start date: 2022-10-01
Primary completion: 2026-10-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.